Ibex Medical Analytics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 99

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $55M

  • Investors
  • 12

Ibex Medical Analytics General Information

Description

Developer of an artificial intelligence-based diagnostics platform designed to assist pathology laboratories. The company offers software that uses machine learning and image analysis to analyze digitized pathology slides and detect cancer and multiple diagnostic features, enabling pathologists to improve diagnostic accuracy and efficiency.

Contact Information

Website
www.ibex-ai.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 Rokach Boulevard
  • Tel Aviv 6153101
  • Israel
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 101 Rokach Boulevard
  • Tel Aviv 6153101
  • Israel

Ibex Medical Analytics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ibex Medical Analytics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series C) 01-Sep-2023 $55M Completed Generating Revenue
8. Later Stage VC (Series B) 20-Jul-2023 Completed Generating Revenue
7. Accelerator/Incubator Completed Generating Revenue
6. Debt - General 25-Aug-2022 Completed Generating Revenue
5. Accelerator/Incubator 13-Jul-2021 Completed Generating Revenue
4. Later Stage VC (Series B) 09-Mar-2021 Completed Generating Revenue
3. Accelerator/Incubator 09-Sep-2019 Completed Generating Revenue
2. Early Stage VC (Series A) 19-Mar-2019 $11M $13.6M Completed Generating Revenue
1. Seed Round 01-Feb-2018 $2.61M $2.61M Completed Startup
To view Ibex Medical Analytics’s complete valuation and funding history, request access »

Ibex Medical Analytics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred B1
Preferred B
Preferred A2
Preferred A1 2,252,880 $0.010000 $4.88 $4.88 1x $4.88 21.09%
Preferred A 661,940 $0.010000 $3.94 $3.94 1x $3.94 6.2%
To view Ibex Medical Analytics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ibex Medical Analytics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence-based diagnostics platform designed to assist pathology laboratories. The compan
Decision/Risk Analysis
Tel Aviv, Israel
99 As of 2026

Cambridge, MA
 

Cloppenburg, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ibex Medical Analytics Competitors (26)

One of Ibex Medical Analytics’s 26 competitors is CancerLinQ, a Private Equity-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CancerLinQ Private Equity-Backed Cambridge, MA
microDimensions Formerly VC-backed Cloppenburg, Germany
Visiopharm Private Equity-Backed Hoersholm, Denmark
Edda Technology Venture Capital-Backed Princeton, NJ
SigTuple Venture Capital-Backed Bengaluru, India
You’re viewing 5 of 26 competitors. Get the full list »

Ibex Medical Analytics Patents

Ibex Medical Analytics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4111411-A1 System and method of managing workflow of examination of pathology slides Inactive 26-Feb-2020
EP-4111411-A4 System and method of managing workflow of examination of pathology slides Inactive 26-Feb-2020
US-20230068571-A1 System and method of managing workflow of examination of pathology slides Inactive 26-Feb-2020
WO-2021171281-A1 System and method of managing workflow of examination of pathology slides Inactive 26-Feb-2020
US-20220005582-A1 System and method for personalization and optimization of digital pathology analysis Inactive 10-Oct-2018 G16H30/20
To view Ibex Medical Analytics’s complete patent history, request access »

Ibex Medical Analytics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ibex Medical Analytics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
NewHealth Ventures Venture Capital Minority
Sienna Venture Capital Venture Capital Minority
Kreos Capital Lender/Debt Provider Minority
Octopus Ventures Venture Capital Minority
Planven Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ibex Medical Analytics FAQs

  • When was Ibex Medical Analytics founded?

    Ibex Medical Analytics was founded in 2016.

  • Where is Ibex Medical Analytics headquartered?

    Ibex Medical Analytics is headquartered in Tel Aviv, Israel.

  • What is the size of Ibex Medical Analytics?

    Ibex Medical Analytics has 99 total employees.

  • What industry is Ibex Medical Analytics in?

    Ibex Medical Analytics’s primary industry is Decision/Risk Analysis.

  • Is Ibex Medical Analytics a private or public company?

    Ibex Medical Analytics is a Private company.

  • What is Ibex Medical Analytics’s current revenue?

    The current revenue for Ibex Medical Analytics is .

  • How much funding has Ibex Medical Analytics raised over time?

    Ibex Medical Analytics has raised $122M.

  • Who are Ibex Medical Analytics’s investors?

    NewHealth Ventures, Sienna Venture Capital, Kreos Capital, Octopus Ventures, and Planven are 5 of 12 investors who have invested in Ibex Medical Analytics.

  • Who are Ibex Medical Analytics’s competitors?

    CancerLinQ, microDimensions, Visiopharm, Edda Technology, and SigTuple are some of the 26 competitors of Ibex Medical Analytics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process